Pharmacokinetics, pharmacodynamics, tolerability and safety of single ascending doses of ticagrelor, a reversibly binding oral P2Y(12) receptor antagonist, in healthy subjects.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Works matching IS 00316970 AND DT 2010 AND VI 66 AND IP 5
Results: 18
1
2
[(13)C]Pantoprazole breath test as a predictor of the anti-platelet function of clopidogrel.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
3
Carriers of the UGT1A4 142T>G gene variant are predisposed to reduced olanzapine exposure -- an impact similar to male gender or smoking in schizophrenic patients.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
4
Nutrition and health: Joseph I. Boullata and Vincent T. Armenti (eds) Handbook of drug-nutrient interactions, 2nd ed.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
5
Superior efficacy of new medicines?
- Published in:
- European Journal of Clinical Pharmacology, 2010, v. 66, n. 5, p. 445, doi. 10.1007/s00228-010-0808-3
- By:
- Publication type:
- Article
6
A fenugreek seed extract selectively reduces spontaneous fat intake in overweight subjects.
- Published in:
- European Journal of Clinical Pharmacology, 2010, v. 66, n. 5, p. 449, doi. 10.1007/s00228-009-0770-0
- By:
- Publication type:
- Article
7
Pharmacokinetics, pharmacodynamics, tolerability and safety of single ascending doses of ticagrelor, a reversibly binding oral P2Y<sub>12</sub> receptor antagonist, in healthy subjects.
- Published in:
- European Journal of Clinical Pharmacology, 2010, v. 66, n. 5, p. 487, doi. 10.1007/s00228-009-0778-5
- By:
- Publication type:
- Article
8
Pattern of drug use during the first trimester among Chinese women: data from a population-based cohort study.
- Published in:
- European Journal of Clinical Pharmacology, 2010, v. 66, n. 5, p. 511, doi. 10.1007/s00228-009-0781-x
- By:
- Publication type:
- Article
9
Differences in the drug prescriptions to children by Italian paediatricians and general practitioners.
- Published in:
- European Journal of Clinical Pharmacology, 2010, v. 66, n. 5, p. 519, doi. 10.1007/s00228-010-0786-5
- By:
- Publication type:
- Article
10
Olanzapine and pancytopenia with severe folate deficiency.
- Published in:
- 2010
- By:
- Publication type:
- Case Study
11
Variability in drug metabolizing enzyme activity in HIV-infected patients.
- Published in:
- European Journal of Clinical Pharmacology, 2010, v. 66, n. 5, p. 475, doi. 10.1007/s00228-009-0777-6
- By:
- Publication type:
- Article
12
Novel strategies for the treatment of inflammatory hyperalgesia.
- Published in:
- European Journal of Clinical Pharmacology, 2010, v. 66, n. 5, p. 429, doi. 10.1007/s00228-010-0784-7
- By:
- Publication type:
- Article
13
Rifampicin reduces the plasma concentrations and the renin-inhibiting effect of aliskiren.
- Published in:
- European Journal of Clinical Pharmacology, 2010, v. 66, n. 5, p. 497, doi. 10.1007/s00228-010-0796-3
- By:
- Publication type:
- Article
14
Effects of Ginkgo biloba extracts on diazepam metabolism: a pharmacokinetic study in healthy Chinese male subjects.
- Published in:
- European Journal of Clinical Pharmacology, 2010, v. 66, n. 5, p. 503, doi. 10.1007/s00228-010-0795-4
- By:
- Publication type:
- Article
15
Nutrition and Health: Joseph I. Boullata and Vincent T. Armenti (eds) Handbook of Drug–Nutrient Interactions, 2nd ed.
- Published in:
- 2010
- By:
- Publication type:
- Book Review
16
Carriers of the UGT1A4 142T>G gene variant are predisposed to reduced olanzapine exposure—an impact similar to male gender or smoking in schizophrenic patients.
- Published in:
- European Journal of Clinical Pharmacology, 2010, v. 66, n. 5, p. 465, doi. 10.1007/s00228-009-0783-8
- By:
- Publication type:
- Article
17
[<sup>13</sup>C]Pantoprazole breath test as a predictor of the anti-platelet function of clopidogrel.
- Published in:
- European Journal of Clinical Pharmacology, 2010, v. 66, n. 5, p. 457, doi. 10.1007/s00228-010-0807-4
- By:
- Publication type:
- Article
18
Increased frequency of CYP2C9 variant alleles and homozygous VKORC1*2B carriers in warfarin-treated patients with excessive INR response.
- Published in:
- European Journal of Clinical Pharmacology, 2010, v. 66, n. 5, p. 525, doi. 10.1007/s00228-010-0813-6
- By:
- Publication type:
- Article